Genera Biosystems Limited (GBI) is a molecular diagnostics
company that develops, manufactures and distributes advanced
molecular diagnostic tests. The company has a development
pipeline of products including novel tests for Chlamydia
trachomatis, and Neisseria gonorrhoea.